EMEA-001720-PIP01-14-M04 - paediatric investigation plan

patiromer sorbitex calcium

Key facts

• Invented name:
  Veltassa
• Active substance:
  patiromer sorbitex calcium
• Therapeutic area:
  Metabolism and nutrition disorders
• Decision number:
  P/0313/2024
• PIP number:
  EMEA-001720-PIP01-14-M04
• Pharmaceutical form(s):
  Powder for oral suspension
• Condition(s) / indication(s):
  Treatment of hyperkalaemia
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  13/09/2024
• Compliance check done:
  No

Decision

P/0313/2024 : EMA decision of 13 September 2024 on the acceptance of a modification of an agreed paediatric investigation plan for patiromer sorbitex calcium (Veltassa), (EMEA-001720-PIP01-14-M04)

Adopted Reference Number: EMA/371127/2024